+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

From
From
From
Type 2 Diabetes Market 2026-2030 - Product Thumbnail Image

Type 2 Diabetes Market 2026-2030

  • Report
  • April 2026
  • 305 Pages
  • Global
From
From
Non-Insulin Diabetes Therapeutics Market 2026-2030 - Product Thumbnail Image

Non-Insulin Diabetes Therapeutics Market 2026-2030

  • Report
  • January 2026
  • 286 Pages
  • Global
From
From
From
From
From
From
Generic Oncology Sterile Injectable Market Report 2026 - Product Thumbnail Image

Generic Oncology Sterile Injectable Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Diabetes Injection Pens Market - Global Forecast 2026-2032 - Product Thumbnail Image

Diabetes Injection Pens Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 193 Pages
  • Global
From
Loading Indicator